Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: Systematic review and meta-analysis

Fertility and Sterility

Volumn 101, Issue 3, 2014, Pages

  Koskas, Martin ^a,b,c,d   Uzan, Jennifer ^a   Luton, Dominique ^a,b   Rouzier, Roman ^d,e   Daraï, Emile ^c,f  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^d Risques Cliniques et Securite en Sante des Femmes et en Sante Perinatale   (France)

^e INSTITUT CURIE   (France)

^f HÔPITAL TENON   (France)

Author keywords

conservative; endometrial atypical hyperplasia; endometrial cancer; Fertility sparing; systematic review

Indexed keywords

GONADORELIN AGONIST; HYDROXYPROGESTERONE CAPROATE; LEVONORGESTREL; MEGESTROL ACETATE; MESOGLYCAN; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; ENDOMETRIAL ATYPICAL HYPERPLASIA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE FERTILITY; FEMALE INFERTILITY; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDLINE; META ANALYSIS; OBESITY; OVULATION INDUCTION; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT DURATION; UNIVERSITY HOSPITAL;

CONSERVATIVE; ENDOMETRIAL ATYPICAL HYPERPLASIA; ENDOMETRIAL CANCER; FERTILITY SPARING; SYSTEMATIC REVIEW;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY PRESERVATION; HUMANS; HYPERPLASIA; PREGNANCY; PROGNOSIS; REPRODUCTION; TREATMENT OUTCOME;

EID: 84894493540     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.11.028     Document Type: Article

References (40)

1. I. Navarria, M. Usel, E. Rapiti, I. Neyroud-Caspar, M.F. Pelte, and C. Bouchardy et al. Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment? Gynecol Oncol 114 2009 448 451
2. M. Koskas, S. Bendifallah, D. Luton, E. Darai, and R. Rouzier Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery Fertil Steril 98 2012 1229 1235
3. C.C. Gunderson, A.N. Fader, K.A. Carson, and R.E. Bristow Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review Gynecol Oncol 125 2012 477 482
4. K. Ushijima, H. Yahata, H. Yoshikawa, I. Konishi, T. Yasugi, and T. Saito et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women J Clin Oncol 25 2007 2798 2803
5. Z. Haoula, M. Salman, and W. Atiomo Evaluating the association between endometrial cancer and polycystic ovary syndrome Hum Reprod 27 2012 1327 1331
6. L.A. Wise, K.J. Rothman, E.M. Mikkelsen, H.T. Sorensen, A. Riis, and E.E. Hatch An internet-based prospective study of body size and time-to-pregnancy Hum Reprod 25 2010 253 264
7. R. Fauvet, C. Poncelet, J. Boccara, P. Descamps, E. Fondrinier, and E. Darai Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study Fertil Steril 83 2005 284 290 quiz 525-6
8. T.C. Randall, and R.J. Kurman Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 Obstet Gynecol 90 1997 434 440
9. P. Jadoul, and J. Donnez Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma Fertil Steril 80 2003 1315 1324
10. G. Laurelli, G. Di Vagno, C. Scaffa, S. Losito, M. Del Giudice, and S. Greggi Conservative treatment of early endometrial cancer: preliminary results of a pilot study Gynecol Oncol 120 2011 43 46
11. L. Minig, D. Franchi, S. Boveri, C. Casadio, L. Bocciolone, and M. Sideri Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women Ann Oncol 22 2011 643 649
12. A.R. Han, Y.S. Kwon, D.Y. Kim, J.H. Kim, Y.M. Kim, and Y.T. Kim et al. Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia Int J Gynecol Cancer 19 2009 147 151
13. T. Minaguchi, S. Nakagawa, Y. Takazawa, T. Nei, K. Horie, and T. Fujiwara et al. Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium Cancer Lett 248 2007 112 122
14. M. Signorelli, G. Caspani, C. Bonazzi, V. Chiappa, P. Perego, and C. Mangioni Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases BJOG 116 2009 114 118
15. M. Yu, J.X. Yang, M. Wu, J.H. Lang, Z. Huo, and K. Shen Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium Fertil Steril 92 2009 2122 2124
16. J.F. Lawless, and K. Singhal Efficient screening of nonnormal regression models Biometrics 34 1978 318 327
17. T. Kaku, H. Yoshikawa, H. Tsuda, A. Sakamoto, M. Fukunaga, and Y. Kuwabara et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome Cancer Lett 167 2001 39 48
18. M. Koskas, S. Bendifallah, D. Luton, E. Darai, and R. Rouzier Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancer Gynecol Oncol 123 2011 214 220
19. S. Bendifallah, A.S. Genin, I. Naoura, N. Chabbert Buffet, F. Clavel Chapelon, and B. Haddad et al. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer Am J Obstet Gynecol 207 2012 197.e1 197.e8
20. Y.B. Kim, C.H. Holschneider, K. Ghosh, R.K. Nieberg, and F.J. Montz Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature Cancer 79 1997 320 327
21. Y. Mao, X. Wan, Y. Chen, W. Lv, and X. Xie Outcomes of conservative therapy for young women with early endometrial adenocarcinoma Fertil Steril 93 2010 283 285
22. R. Homburg Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy Hum Reprod 11 1996 29 39
23. C.A. Amezcua, W. Zheng, L.I. Muderspach, and J.C. Felix Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia Gynecol Oncol 73 1999 126 136
24. A.E. Schindler, C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, and K.W. Schweppe et al. Classification and pharmacology of progestins Maturitas 61 2008 171 180
25. H. Adlercreutz, P.B. Eriksen, and M.S. Christensen Plasma concentrations of megestrol acetate and medroxyprogesterone acetate after single oral administration to healthy subjects J Pharm Biomed Anal 1 1983 153 162
26. J.T. Thigpen, M.F. Brady, R.D. Alvarez, M.D. Adelson, H.D. Homesley, and A. Manetta et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group J Clin Oncol 17 1999 1736 1744
27. I.D. Gallos, R. Ganesan, and J.K. Gupta Prediction of regression and relapse of endometrial hyperplasia with conservative therapy Obstet Gynecol 121 2013 1165 1171
28. S.E. Elizur, M.E. Beiner, J. Korach, A. Weiser, G. Ben-Baruch, and J. Dor Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma Fertil Steril 88 2007 1562 1567
29. L.R. Duska, A. Garrett, B.R. Rueda, J. Haas, Y. Chang, and A.F. Fuller Endometrial cancer in women 40 years old or younger Gynecol Oncol 83 2001 388 393
30. H. Fujiwara, S. Ogawa, M. Motoyama, Y. Takei, S. Machida, and A. Taneichi et al. Frequency and characteristics of endometrial carcinoma and atypical hyperplasia detected on routine infertility investigations in young women: a report of six cases Hum Reprod 24 2009 1045 1050
31. W.H. Gotlieb, M.E. Beiner, B. Shalmon, Y. Korach, Y. Segal, and N. Zmira et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer Obstet Gynecol 102 2003 718 725
32. M. Imai, T. Jobo, R. Sato, M. Kawaguchi, and H. Kuramoto Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations Eur J Gynaecol Oncol 22 2001 217 220
33. I. Mazzon, G. Corrado, V. Masciullo, D. Morricone, G. Ferrandina, and G. Scambia Conservative surgical management of stage IA endometrial carcinoma for fertility preservation Fertil Steril 93 2009 1286 1289
34. K. Niwa, K. Tagami, Z. Lian, K. Onogi, H. Mori, and T. Tamaya Outcome of fertility-preserving treatment in young women with endometrial carcinomas BJOG 112 2005 317 320
35. T. Ota, M. Yoshida, M. Kimura, and K. Kinoshita Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger Int J Gynecol Cancer 15 2005 657 662
36. S. Stanosz An attempt at conservative treatment in selected cases of type I endometrial carcinoma (stage I a/G1) in young women Eur J Gynaecol Oncol 30 2009 365 369
37. C.B. Wang, C.J. Wang, H.J. Huang, S. Hsueh, H.H. Chou, and Y.K. Soong et al. Fertility-preserving treatment in young patients with endometrial adenocarcinoma Cancer 94 2002 2192 2198
38. T. Yahata, K. Fujita, Y. Aoki, and K. Tanaka Long-term conservative therapy for endometrial adenocarcinoma in young women Hum Reprod 21 2006 1070 1075
39. K. Yamazawa, M. Hirai, A. Fujito, H. Nishi, F. Terauchi, and H. Ishikura et al. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer Hum Reprod 22 2007 1953 1958
40. Y.C. Yang, C.C. Wu, C.P. Chen, C.L. Chang, and K.L. Wang Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer Gynecol Oncol 99 2005 287 293